Oncolytics Biotech, Inc.
(Toronto Stock Exchange : ONCY)

( )
ONCY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.07%200.801.3%$462.93m
BIIBBiogen Inc.
0.09%223.211.3%$371.70m
GILDGilead Sciences, Inc.
-0.47%63.690.9%$361.30m
CELGCelgene Corporation
0.76%100.571.3%$359.89m
ILMNIllumina, Inc.
1.48%302.583.5%$282.38m
REGNRegeneron Pharmaceuticals, Inc.
0.81%300.772.6%$210.74m
EXASExact Sciences Corporation
2.19%92.5024.1%$193.04m
VRTXVertex Pharmaceuticals Incorporated
1.29%172.411.9%$181.51m
ALXNAlexion Pharmaceuticals, Inc.
0.92%99.252.0%$176.54m
AAgilent Technologies, Inc.
1.77%75.311.6%$166.98m
SRPTSarepta Therapeutics, Inc.
0.39%83.4814.6%$138.14m
ALDRAlder Biopharmaceuticals, Inc.
-0.05%18.8710.2%$125.33m
BMRNBioMarin Pharmaceutical Inc.
1.29%67.364.3%$96.05m
ACADACADIA Pharmaceuticals Inc.
0.10%40.5213.4%$95.97m
INCYIncyte Corporation
0.46%76.122.5%$87.99m

Company Profile

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.